Literature DB >> 21648289

HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes.

Petra Dusatkova1, Stepanka Pruhova, Zdenek Sumnik, Stanislava Kolouskova, Barbora Obermannova, Ondrej Cinek, Jan Lebl.   

Abstract

BACKGROUND: HNF1A-MODY (MODY3) is a common subtype of autosomal dominant diabetes. Unlike HNF4-MODY where fetal macrosomia and early postnatal hyperinsulinemic hypoglycemia have been reported, history of transient insulin overproduction has not yet been recognized in individuals with HNF1A-MODY. CASE REPORT: Here, we report on a 40-year-old male patient with HNF1A mutation p.Arg272His (c.815G>A) having a history of fetal macrosomia (4750 g, 59 cm), and, at least, one attack of symptomatic hypoglycemia in childhood. Diabetes was subsequently diagnosed at 19 years of age. The proband's daughter who developed diabetes at 16 years carries the same mutation, but her birth weight and length were in the upper normal range, and she never experienced hypoglycemic symptoms.
CONCLUSION: The observation of fetal macrosomia and hypoglycemia in childhood is indicative of a biphasic impact of the HNF1A mutation on p-cell function over the lifespan, leading from inappropriate insulin oversecretion to final clinical diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21648289     DOI: 10.1515/jpem.2011.083

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  Localized islet nuclear enlargement hyperinsulinism (LINE-HI) due to ABCC8 and GCK mosaic mutations.

Authors:  Kara E Boodhansingh; Zhongying Yang; Changhong Li; Pan Chen; Katherine Lord; Susan A Becker; Lisa J States; N Scott Adzick; Tricia Bhatti; Show-Ling Shyng; Arupa Ganguly; Charles A Stanley; Diva D De Leon
Journal:  Eur J Endocrinol       Date:  2022-06-27       Impact factor: 6.558

2.  The birth weight lowering C-allele of rs900400 near LEKR1 and CCNL1 associates with elevated insulin release following an oral glucose challenge.

Authors:  Ehm A Andersson; Marie N Harder; Kasper Pilgaard; Charlotta Pisinger; Alena Stančáková; Johanna Kuusisto; Niels Grarup; Kristine Færch; Pernille Poulsen; Daniel R Witte; Torben Jørgensen; Allan Vaag; Markku Laakso; Oluf Pedersen; Torben Hansen
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

Review 3.  The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia.

Authors:  Klára Roženková; Maria Güemes; Pratik Shah; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-06

4.  Novel dominant KATP channel mutations in infants with congenital hyperinsulinism: Validation by in vitro expression studies and in vivo carrier phenotyping.

Authors:  Kara E Boodhansingh; Balamurugan Kandasamy; Lauren Mitteer; Stephanie Givler; Diva D De Leon; Show-Ling Shyng; Arupa Ganguly; Charles A Stanley
Journal:  Am J Med Genet A       Date:  2019-08-28       Impact factor: 2.802

5.  Aberrant development of pancreatic beta cells derived from human iPSCs with FOXA2 deficiency.

Authors:  Ahmed K Elsayed; Ihab Younis; Gowher Ali; Khalid Hussain; Essam M Abdelalim
Journal:  Cell Death Dis       Date:  2021-01-20       Impact factor: 8.469

6.  Report of Prolonged Neonatal Hypoglycemia in Three Infants of Mothers With HNF1A Maturity-Onset Diabetes of the Youth.

Authors:  Sara Jane Cromer; Aluma Chovel Sella; Emily Rosenberg; Kevin Scully; Marie McDonnell; Ana Paula Abreu; Michelle Weil; Sarah N Bernstein; Maryanne Quinn; Camille Powe; Deborah M Mitchell; Miriam S Udler
Journal:  AACE Clin Case Rep       Date:  2022-08-08

Review 7.  Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes.

Authors:  Antonella Marucci; Irene Rutigliano; Grazia Fini; Serena Pezzilli; Claudia Menzaghi; Rosa Di Paola; Vincenzo Trischitta
Journal:  Genes (Basel)       Date:  2022-01-09       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.